About Jackie Kent
Form D filings for Curavit Clinical Research in 2024 list Jackie Kent as director.
Jackie Kent first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jackie Kent in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jackie Kent works with at each company, as listed on that company's latest Form D.
Curavit Clinical Research Corp · Form D/A, Sep 5, 2024
RL
Rich Lester
Director
JM
Joel Morse
Chief Executive Officer and director
NL
Nathanael Lentz
Director
DH
David Hanaman
Director